These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3700037)

  • 1. Biochemical and biological activity of the anthracycline analog, 4-demethyl-6-O-methyl-doxorubicin.
    Zunino F; Barbieri B; Bellini O; Casazza AM; Geroni C; Giuliani F; Ciana A; Manzini G; Quadrifoglio F
    Invest New Drugs; 1986; 4(1):17-23. PubMed ID: 3700037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
    Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F
    Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin.
    Nakai K; Takagi Y; Ogawa S; Tsuchiya T
    Carbohydr Res; 1999 Jul; 320(1-2):8-18. PubMed ID: 10515060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).
    Gao YG; Wang AH
    Anticancer Drug Des; 1991 Jul; 6(3):137-49. PubMed ID: 1872945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
    Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
    Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross resistance and cellular uptake of 4'-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin.
    Di Marco A; Skovsgaard T; Casazza AM; Pratesi G; Nissen NI; Danø K
    Cancer Chemother Pharmacol; 1981; 7(1):15-20. PubMed ID: 7340984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite.
    Minotti G; Licata S; Saponiero A; Menna P; Calafiore AM; Di Giammarco G; Liberi G; Animati F; Cipollone A; Manzini S; Maggi CA
    Chem Res Toxicol; 2000 Dec; 13(12):1336-41. PubMed ID: 11123976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DA-125, a novel anthracycline derivative showing high-affinity DNA binding and topoisomerase II inhibitory activities, exerts cytotoxicity via c-Jun N-terminal kinase pathway.
    Kim SG; Sung M; Kang KW; Kim SH; Son MH; Kim WB
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):511-8. PubMed ID: 11459204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.
    Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Cancer Chemother Pharmacol; 1978; 1(4):249-54. PubMed ID: 750112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenografts.
    Taetle R; Howell SB; Giuliani FC; Koziol J; Koessler A
    Cancer; 1982 Oct; 50(8):1455-61. PubMed ID: 6956427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.
    Ripamonti M; Pezzoni G; Pesenti E; Pastori A; Farao M; Bargiotti A; Suarato A; Spreafico F; Grandi M
    Br J Cancer; 1992 May; 65(5):703-7. PubMed ID: 1586598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
    Aubel-Sadron G; Londos-Gagliardi D
    Biochimie; 1984 May; 66(5):333-52. PubMed ID: 6380596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
    Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
    Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
    J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.